Cisplatin / Carboplatin and Etoposide with or without Nivolumab in Treating Patients with Extensive Stage Lung Cancer

< Back to search results
This clinical trial matches:
Show Search Criteria
Status: Active

Description

This randomized phase II clinical trial studies how well cisplatin, carboplatin, and etoposide work when given together with nivolumab in treating patients with extensive stage lung cancer. Drugs used in chemotherapy, such as cisplatin, carboplatin, and etoposide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Giving cisplatin, carboplatin, and etoposide together with nivolumab may work better in treating patients with extensive stage lung cancer.

Eligibility Criteria

Inclusion Criteria

  • Patients must have histologically or cytologically confirmed extensive stage small cell lung cancer and must be a candidate for systemic therapy; NOTE: The extensive disease SCLC classification for this protocol includes all patients with disease sites not defined as limited stage; limited stage disease category includes patients with disease restricted to one hemithorax with regional lymph node metastases, including hilar, ipsilateral and contralateral mediastinal, and/or ipsilateral supraclavicular nodes; extensive disease patients are defined as those patients with extrathoracic metastatic disease, malignant pleural effusion, bilateral or contralateral supraclavicular adenopathy
  • Patients must have measurable disease based on Response Evaluation Criteria in Solid Tumors (RECIST) 1.1
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
  • Absolute neutrophil count >= 1,500/mm^3 must be obtained =< 7 days prior to protocol registration
  • Platelets >= 100,000/mm^3 must be obtained =< 7 days prior to protocol registration
  • Leukocytes >= 3000/mm^3 must be obtained =< 7 days prior to protocol registration
  • Hemoglobin >= 9 g/dL must be obtained =< 7 days prior to protocol registration
  • Total bilirubin =< 1.5 X institutional upper limit of normal (ULN) (except subjects with Gilbert syndrome, who can have total bilirubin < 3 mg/dL) must be obtained =< 7 days prior to protocol registration
  • Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) and alanine aminotransferase (ALT) (serum glutamic pyruvic transaminase [SGPT]) =< 3 X institutional upper limit of normal (ULN) (=< 5 X if liver function test [LFT] elevations due to known liver metastases) must be obtained =< 7 days prior to protocol registration
  • Serum creatinine =< 1.5 x ULN or calculated creatinine clearance > 50 mL/min (using the Cockcroft-Gault formula) must be obtained =< 7 days prior to protocol registration
  • Patients are eligible if central nervous system (CNS) metastases are adequately treated and neurological symptoms have returned to baseline or are controlled for at least 2 weeks prior to enrollment; in addition, subjects must be either off corticosteroids, or on a stable or decreasing dose of =< 10 mg daily prednisone (or equivalent); patients with untreated CNS metastases are eligible if they are not symptomatic and the lesions are less than 1 cm in size
  • Patients cannot have had prior chemotherapy or biologic therapy for small cell lung cancer for front line treatment; patients receiving prior whole brain radiation cannot register within 7 days after completion of radiation, and must have resolved adverse events attributed to radiation to =< grade 1
  • Patients who have received prior chemoradiation for limited-stage SCLC must have been treated with curative intent at least 6 months since last treatment from diagnosis of extensive-stage SCLC
  • Patients may not be receiving any other investigational agents while on study
  • Patients must not have history of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab or other agents used in the study
  • Women must not be pregnant or breast-feeding; breastfeeding must be discontinued or the subject is not eligible for the study; all females of childbearing potential must have a blood test or urine study within 14 days prior to registration to rule out pregnancy; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 24 consecutive months (i.e. has had menses at any time in the preceding 24 consecutive months)
  • Women of childbearing potential (WOCBP) and males who are sexually active with WOCBP must use an accepted and effective method of contraception or abstain from sexual intercourse for at least one week prior to the start of treatment, and continue for 5 months after the last dose of protocol treatment for women of childbearing potential and 7 months after the last dose of protocol treatment for males who are sexually active with WOCBP
  • No prior or current invasive malignancy (except non-melanomatous skin cancer, localized bladder and prostate cancer) unless disease free for a minimum of 2 years (for example, carcinoma in situ of the breast, oral cavity, or cervix are all permissible);
  • No prior systemic treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell costimulation or immune checkpoint pathways;
  • Patient must not have leptomeningeal disease
  • No patients with an active, known or suspected autoimmune disease and neuromuscular paraneoplastic syndromes including but not limited to myasthenia gravis, Lambert-Eaton myasthenic syndrome, limbic encephalitis, myositis, Guillain-Barre; subjects with type I diabetes mellitus, hypothyroidism only requiring hormone replacement, skin disorders (such as vitiligo, psoriasis, or alopecia) not requiring systemic treatment, or conditions not expected to recur in the absence of an external trigger are permitted to enroll
  • No patients with a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalent) or other immunosuppressive medications within 7 days of randomization; inhaled or topical steroids, and adrenal replacement steroid doses > 10 mg daily prednisone equivalent, are permitted in the absence of active autoimmune disease
  • No patients with interstitial lung disease that is symptomatic or may interfere with the detection or management of suspected drug-related pulmonary toxicity
  • Patients must NOT have uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
  • Human immunodeficiency virus (HIV)-positive patients on combination antiretroviral therapy are ineligible
  • Any positive test for hepatitis B virus or hepatitis C virus indicating acute or chronic infection, patients are excluded
  • Patients are ineligible if administration of a live, attenuated vaccine within 4 weeks before randomization
  • No history of severe hypersensitivity reaction to any monoclonal antibody or allergy to study drug components;

Locations & Contacts

California

Arroyo Grande
PCR Oncology
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Vacaville
Northbay Cancer Center
Status: Active
Contact: Brian G. Vikstrom
Phone: 707-624-8007

Colorado

Aurora
Rocky Mountain Cancer Centers-Aurora
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Boulder
Boulder Community Hospital
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: jbloomfield@co-cancerresearch.org
Rocky Mountain Cancer Centers-Boulder
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Denver
Colorado Blood Cancer Institute
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Denver Health Medical Center
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
National Jewish Health-Main Campus
Status: Active
Contact: Keren Sturtz
Phone: 877-225-5654 Email: glicht@co-cancerresearch.org
Presbyterian - Saint Lukes Medical Center - Health One
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Rocky Mountain Cancer Centers-Midtown
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Rocky Mountain Cancer Centers-Rose
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Rose Medical Center
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
SCL Health Saint Joseph Hospital
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
The Women's Imaging Center
Status: Active
Contact: Keren Sturtz Email: ecog.rss@jimmy.harvard.edu
Western Surgical Care
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Englewood
Comprehensive Cancer Care and Research Institute of Colorado LLC
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Swedish Medical Center
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Golden
National Jewish Health-Western Hematology Oncology
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: glicht@co-cancerresearch.org
Grand Junction
Saint Mary's Hospital and Regional Medical Center
Status: Active
Contact: Keren Sturtz Email: ecog.rss@jimmy.harvard.edu
Greeley
North Colorado Medical Center
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Lafayette
Good Samaritan Medical Center
Status: Active
Contact: Keren Sturtz
Phone: 303-673-1622
Littleton
Rocky Mountain Cancer Centers-Littleton
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Lone Tree
Rocky Mountain Cancer Centers-Sky Ridge
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Loveland
McKee Medical Center
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Thornton
National Jewish Health-Northern Hematology Oncology
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: glicht@co-cancerresearch.org
Wheat Ridge
SCL Health Lutheran Medical Center
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org

Connecticut

Middletown
Middlesex Hospital
Status: Active
Contact: Susanna Hong
Phone: 860-358-2058 Email: beth_slifer@midhosp.org

Florida

Pensacola
Sacred Heart Hospital
Status: Active
Contact: Yazan Alsayed
Phone: 850-416-4611 Email: eebrou@ascension.org

Georgia

Atlanta
Northside Hospital
Status: Active
Contact: Sreekanth C. Reddy
Phone: 404-303-3355 Email: ClinicalTrials@northside.com
Cumming
Northside Hospital-Forsyth
Status: Active
Contact: Sreekanth C. Reddy
Phone: 404-303-3355 Email: clinicaltrials@northside.com

Idaho

Boise
Saint Alphonsus Cancer Care Center-Boise
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Caldwell
Saint Alphonsus Cancer Care Center-Caldwell
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Coeur D'Alene
Kootenai Medical Center
Status: Active
Contact: Benjamin T. Marchello
Phone: 406-969-6060 Email: mccinfo@mtcancer.org
Emmett
Walter Knox Memorial Hospital
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Meridian
Idaho Urologic Institute-Meridian
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Nampa
Saint Alphonsus Medical Center-Nampa
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Post Falls
Kootenai Cancer Center
Status: Active
Contact: Benjamin T. Marchello
Phone: 406-969-6060 Email: mccinfo@mtcancer.org
Sandpoint
Kootenai Cancer Clinic
Status: Active
Contact: Benjamin T. Marchello
Phone: 406-969-6060 Email: mccinfo@mtcancer.org

Illinois

Bloomington
Illinois CancerCare-Bloomington
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Canton
Illinois CancerCare-Canton
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Carbondale
Memorial Hospital of Carbondale
Status: Active
Contact: Bryan A. Faller
Phone: 618-457-5200 Email: clinical.research@sih.net
Carterville
SIH Cancer Institute
Status: Active
Contact: Bryan A. Faller
Phone: 618-985-3333 Email: clinical.research@sih.net
Carthage
Illinois CancerCare-Carthage
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Centralia
Centralia Oncology Clinic
Status: Active
Contact: Bryan A. Faller
Phone: 217-876-4740 Email: rhamrick@dmhhs.org
Chicago
John H Stroger Jr Hospital of Cook County
Status: Active
Contact: Thomas E. Lad
Phone: 312-864-5204
Decatur
Cancer Care Specialists of Central Illinois
Status: Active
Contact: Bryan A. Faller
Phone: 217-876-4740 Email: rhamrick@dmhhs.org
Decatur Memorial Hospital
Status: Active
Contact: Bryan A. Faller
Phone: 217-876-4740 Email: rhamrick@dmhhs.org
Effingham
Crossroads Cancer Center
Status: Active
Contact: Bryan A. Faller
Phone: 217-876-4740 Email: rhamrick@dmhhs.org
Eureka
Illinois CancerCare-Eureka
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Galesburg
Illinois CancerCare-Galesburg
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Western Illinois Cancer Treatment Center
Status: Active
Contact: Bryan A. Faller
Phone: 309-344-2831
Joliet
Joliet Oncology-Hematology Associates Limited
Status: Active
Contact: Nafisa D. Burhani
Phone: 815-730-3098 Email: maureenc@jolietoncology.com
Kewanee
Illinois CancerCare-Kewanee Clinic
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Macomb
Illinois CancerCare-Macomb
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Maywood
Loyola University Medical Center
Status: Active
Contact: Courtney Regan Wagner
Phone: 708-226-4357
Melrose Park
Marjorie Weinberg Cancer Center at Loyola-Gottlieb
Status: Active
Contact: Courtney Regan Wagner
Phone: 708-450-4554
Ottawa
Illinois CancerCare-Ottawa Clinic
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Pekin
Illinois CancerCare-Pekin
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Peoria
Illinois CancerCare-Peoria
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Methodist Medical Center of Illinois
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Peru
Illinois CancerCare-Peru
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Valley Radiation Oncology
Status: Active
Contact: Bryan A. Faller
Phone: 815-664-4141
Princeton
Illinois CancerCare-Princeton
Status: Active
Contact: Bryan A. Faller
Phone: 309-243-3605 Email: andersonj@illinoiscancercare.com
Springfield
Memorial Medical Center
Status: Active
Contact: Bryan A. Faller
Phone: 217-788-3528
Southern Illinois University School of Medicine
Status: Active
Contact: Bryan A. Faller
Phone: 217-545-7929
Springfield Clinic
Status: Active
Contact: Bryan A. Faller
Phone: 800-444-7541
Swansea
Cancer Care Specialists of Illinois-Swansea
Status: Active
Contact: Bryan A. Faller
Phone: 217-876-4740 Email: rhamrick@dmhhs.org
Memorial and Saint Elizabeth's Health Care Services LLP
Status: Active
Contact: Bryan A. Faller Email: ecog.rss@jimmy.harvard.edu

Indiana

Richmond
Reid Health
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu

Iowa

Des Moines
Broadlawns Medical Center
Status: Active
Contact: Robert J. Behrens
Phone: 515-282-2200
Iowa Lutheran Hospital
Status: Active
Contact: Robert J. Behrens
Phone: 515-241-8704
Iowa Methodist Medical Center
Status: Active
Contact: Robert J. Behrens
Phone: 515-241-6727
Medical Oncology and Hematology Associates-Des Moines
Status: Active
Contact: Robert J. Behrens
Phone: 515-282-2921
West Des Moines
Methodist West Hospital
Status: Active
Contact: Robert J. Behrens
Phone: 515-343-1000

Kansas

Lawrence
Lawrence Memorial Hospital
Status: Active
Contact: Shaker R. Dakhil
Phone: 316-268-5374 Email: Keisha.humphries@ascension.org
Wichita
Cancer Center of Kansas - Wichita
Status: Active
Contact: Shaker R. Dakhil
Phone: 316-268-5374 Email: Keisha.humphries@ascension.org
Cancer Center of Kansas-Wichita Medical Arts Tower
Status: Active
Contact: Shaker R. Dakhil
Phone: 316-268-5374 Email: Keisha.humphries@ascension.org

Kentucky

Edgewood
Saint Elizabeth Medical Center South
Status: Active
Contact: Colleen M. Darnell
Phone: 859-301-5473 Email: darla.hehman@stelizabeth.com
Fort Thomas
Saint Elizabeth Fort Thomas
Status: Active
Contact: Colleen M. Darnell
Phone: 859-301-9418

Louisiana

Baton Rouge
Medical Center of Baton Rouge
Status: Active
Contact: Suma P. Satti
Phone: 225-761-5346 Email: Camille.Beck@Ochsner.org
Ochsner Health Center-Summa
Status: Active
Contact: Suma P. Satti
Phone: 225-761-5346 Email: Camille.Beck@Ochsner.org
New Orleans
Ochsner Medical Center Jefferson
Status: Active
Contact: Suma P. Satti
Phone: 504-703-8712 Email: Gregory.Johnstone@ochsner.org

Maine

Bangor
Eastern Maine Medical Center
Status: Active
Contact: Thomas H. Openshaw
Phone: 207-973-4274
Brewer
Lafayette Family Cancer Center-EMMC
Status: Active
Contact: Thomas H. Openshaw
Phone: 800-987-3005

Maryland

Baltimore
Greater Baltimore Medical Center
Status: Active
Contact: Mei Tang
Phone: 443-849-3706
Frederick
Frederick Memorial Hospital
Status: Active
Contact: Elhamy D. Eskander
Phone: 240-566-3584 Email: clinicaltrials@fmh.org

Massachusetts

Beverly
Beverly Hospital
Status: Active
Name Not Available
Phone: 978-922-3000ext2405
Burlington
Lahey Hospital and Medical Center
Status: Active
Contact: Paul Joseph Hesketh
Phone: 781-744-8027
Fitchburg
Simonds-Sinon Regional Cancer Center
Status: Active
Contact: William V. Walsh
Phone: 978-343-5670
Gloucester
Addison Gilbert Hospital
Status: Active
Name Not Available
Phone: 978-283-4000ext559
Lowell
Lowell General Hospital
Status: Active
Contact: Richard M. Zuniga
Phone: 978-788-7084 Email: ghincks@lowellgeneral.org
Winchester
Winchester Hospital
Status: Active
Contact: Paul Joseph Hesketh
Phone: 888-823-5923 Email: ctsucontact@westat.com
Worcester
University of Massachusetts Medical School
Status: Active
Contact: William V. Walsh
Phone: 508-856-3216 Email: cancer.research@umassmed.edu

Michigan

Adrian
Hickman Cancer Center
Status: Active
Contact: Rex B. Mowat
Phone: 517-265-0116
Ann Arbor
Saint Joseph Mercy Hospital
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Battle Creek
Bronson Battle Creek
Status: Active
Contact: Kathleen J. Yost
Phone: 616-391-1230 Email: crcwm-regulatory@crcwm.org
Brighton
IHA Hematology Oncology Consultants-Brighton
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Saint Joseph Mercy Brighton
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Canton
IHA Hematology Oncology Consultants-Canton
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Saint Joseph Mercy Canton
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Caro
Caro Cancer Center
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Chelsea
IHA Hematology Oncology Consultants-Chelsea
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Saint Joseph Mercy Chelsea
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Clarkston
Hematology Oncology Consultants-Clarkston
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Newland Medical Associates-Clarkston
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Detroit
Saint John Hospital and Medical Center
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
East China
Great Lakes Cancer Management Specialists-Doctors Park
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Escanaba
Green Bay Oncology - Escanaba
Status: Active
Contact: Brian Leslie Burnette
Phone: 920-433-8889 Email: Christy.Gilchrist@hshs.org
Flint
Genesee Cancer and Blood Disease Treatment Center
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Genesee Hematology Oncology PC
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Genesys Hurley Cancer Institute
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Hurley Medical Center
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Gorsse Pointe Woods
Lymphoma Clinic of Michigan
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Grand Rapids
Mercy Health Saint Mary's
Status: Active
Contact: Kathleen J. Yost Email: ecog.rss@jimmy.harvard.edu
Spectrum Health at Butterworth Campus
Status: Active
Contact: Kathleen J. Yost
Phone: 616-391-1230 Email: crcwm-regulatory@crcwm.org
Grosse Pointe Woods
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Michigan Breast Specialists-Grosse Pointe Woods
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Kalamazoo
Borgess Medical Center
Status: Active
Contact: Kathleen J. Yost
Phone: 616-391-1230 Email: crcwm-regulatory@crcwm.org
Bronson Methodist Hospital
Status: Active
Contact: Kathleen J. Yost
Phone: 616-391-1230 Email: crcwm-regulatory@crcwm.org
West Michigan Cancer Center
Status: Active
Contact: Kathleen J. Yost
Phone: 616-391-1230 Email: crcwm-regulatory@crcwm.org
Lansing
Sparrow Hospital
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Livonia
Hope Cancer Clinic
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Saint Mary Mercy Hospital
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Macomb Township
Great Lakes Cancer Management Specialists-Macomb Medical Campus
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Michigan Breast Specialists-Macomb Township
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Marlette
Saint Mary's Oncology / Hematology Associates of Marlette
Status: Active
Contact: Philip J. Stella
Phone: 989-343-2487
Monroe
Toledo Clinic Cancer Centers-Monroe
Status: Active
Contact: Rex B. Mowat
Phone: 800-444-3561
Muskegon
Mercy Health Mercy Campus
Status: Active
Contact: Kathleen J. Yost
Phone: 616-391-1230 Email: crcwm-regulatory@crcwm.org
Niles
Lakeland Hospital Niles
Status: Active
Name Not Available Email: ecog.rss@jimmy.harvard.edu
Pontiac
21st Century Oncology-Pontiac
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Hope Cancer Center
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Newland Medical Associates-Pontiac
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Saint Joseph Mercy Oakland
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Port Huron
Huron Medical Center PC
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Lake Huron Medical Center
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Reed City
Spectrum Health Reed City Hospital
Status: Active
Contact: Kathleen J. Yost
Phone: 616-391-1230 Email: crcwm-regulatory@crcwm.org
Rochester Hills
Great Lakes Cancer Management Specialists-Rochester Hills
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Saginaw
Oncology Hematology Associates of Saginaw Valley PC
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Saint Mary's of Michigan
Status: Active
Contact: Philip J. Stella Email: ecog.rss@jimmy.harvard.edu
Saint Joseph
Lakeland Medical Center Saint Joseph
Status: Active
Contact: Kathleen J. Yost
Phone: 616-391-1230 Email: crcwm-regulatory@crcwm.org
Marie Yeager Cancer Center
Status: Temporarily closed to accrual
Name Not Available
Phone: 616-391-1230 Email: crcwm-regulatory@crcwm.org
Sterling Heights
Bhadresh Nayak MD PC-Sterling Heights
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Tawas City
Saint Joseph Health System-Tawas City
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Traverse City
Munson Medical Center
Status: Active
Contact: Kathleen J. Yost
Phone: 616-391-1230 Email: crcwm-regulatory@crcwm.org
Warren
Advanced Breast Care Center PLLC
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Great Lakes Cancer Management Specialists-Macomb Professional Building
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Macomb Hematology Oncology PC
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Michigan Breast Specialists-Warren
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Saint John Macomb-Oakland Hospital
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
West Branch
Saint Mary's Oncology / Hematology Associates of West Branch
Status: Active
Contact: Philip J. Stella
Phone: 989-343-2487
Wyoming
Metro Health Hospital
Status: Active
Contact: Kathleen J. Yost
Phone: 616-391-1230 Email: crcwm-regulatory@crcwm.org
Ypsilanti
Huron Gastroenterology PC
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
IHA Hematology Oncology Consultants-Ann Arbor
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org

Minnesota

Bemidji
Sanford Clinic North-Bemidgi
Status: Active
Contact: Preston D. Steen
Phone: 218-333-5000
Burnsville
Fairview Ridges Hospital
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Coon Rapids
Mercy Hospital
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Edina
Fairview-Southdale Hospital
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Fridley
Unity Hospital
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Maple Grove
Fairview Maple Grove Medical Center
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Maplewood
Minnesota Oncology Hematology PA-Maplewood
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Saint John's Hospital - Healtheast
Status: Active
Contact: David Mark King Email: ecog.rss@jimmy.harvard.edu
Minneapolis
Abbott-Northwestern Hospital
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Health Partners Inc
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Hennepin County Medical Center
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
New Ulm
New Ulm Medical Center
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Robbinsdale
North Memorial Medical Health Center
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Saint Louis Park
Park Nicollet Clinic - Saint Louis Park
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Saint Paul
Regions Hospital
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
United Hospital
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Shakopee
Saint Francis Regional Medical Center
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Stillwater
Lakeview Hospital
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Waconia
Ridgeview Medical Center
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Willmar
Rice Memorial Hospital
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Woodbury
Minnesota Oncology Hematology PA-Woodbury
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Wyoming
Fairview Lakes Medical Center
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com

Mississippi

Pascagoula
Singing River Hospital
Status: Active
Contact: James E. Clarkson
Phone: 228-809-5292

Missouri

Bonne Terre
Parkland Health Center-Bonne Terre
Status: Active
Contact: Bryan A. Faller
Phone: 314-996-5569
Cape Girardeau
Saint Francis Medical Center
Status: Active
Contact: Bryan A. Faller
Phone: 573-334-2230 Email: sfmc@sfmc.net
Southeast Cancer Center
Status: Active
Contact: Bryan A. Faller
Phone: 573-651-5550
Jefferson City
Capital Region Southwest Campus
Status: Active
Contact: Bryan A. Faller
Phone: 573-632-4814 Email: swooden@mail.crmc.org
Sainte Genevieve
Sainte Genevieve County Memorial Hospital
Status: Active
Contact: Bryan A. Faller
Phone: 314-996-5569
Sullivan
Missouri Baptist Sullivan Hospital
Status: Active
Contact: Bryan A. Faller
Phone: 314-996-5569
Sunset Hills
Missouri Baptist Outpatient Center-Sunset Hills
Status: Active
Contact: Bryan A. Faller
Phone: 314-996-5569

Montana

Anaconda
Community Hospital of Anaconda
Status: Active
Contact: Benjamin T. Marchello
Phone: 406-969-6060 Email: mccinfo@mtcancer.org
Billings
Billings Clinic Cancer Center
Status: Active
Contact: Benjamin T. Marchello
Phone: 800-996-2663 Email: research@billingsclinic.org
Saint Vincent Frontier Cancer Center
Status: Active
Contact: Keren Sturtz
Phone: 800-648-6274
Saint Vincent Healthcare
Status: Active
Contact: Keren Sturtz
Phone: 406-969-6060 Email: mccinfo@mtcancer.org
Bozeman
Bozeman Deaconess Hospital
Status: Active
Contact: Benjamin T. Marchello
Phone: 406-969-6060 Email: mccinfo@mtcancer.org
Butte
Saint James Community Hospital and Cancer Treatment Center
Status: Active
Contact: Keren Sturtz
Phone: 406-723-2621
Great Falls
Benefis Healthcare- Sletten Cancer Institute
Status: Active
Contact: Benjamin T. Marchello
Phone: 406-969-6060 Email: mccinfo@mtcancer.org
Great Falls Clinic
Status: Active
Contact: Benjamin T. Marchello
Phone: 406-969-6060 Email: mccinfo@mtcancer.org
Helena
Saint Peter's Community Hospital
Status: Active
Contact: Benjamin T. Marchello Email: ecog.rss@jimmy.harvard.edu
Kalispell
Kalispell Regional Medical Center
Status: Active
Contact: Benjamin T. Marchello
Phone: 406-969-6060 Email: mccinfo@mtcancer.org
Missoula
Community Medical Hospital
Status: Active
Contact: Benjamin T. Marchello
Phone: 406-969-6060 Email: mccinfo@mtcancer.org

Nebraska

Lincoln
Nebraska Cancer Research Center
Status: Active
Contact: Gamini S. Soori
Phone: 800-487-8786
Nebraska Hematology and Oncology
Status: Active
Contact: Gamini S. Soori
Phone: 402-484-4911
Southeast Nebraska Cancer Center
Status: Active
Contact: Gamini S. Soori
Phone: 402-327-7363
Norfolk
Faith Regional Health Services Carson Cancer Center
Status: Active
Contact: Gamini S. Soori
Phone: 402-991-0070 Email: mwilwerding@canceralliance-ne.org
North Platte
Great Plains Health Callahan Cancer Center
Status: Active
Contact: Gamini S. Soori
Phone: 402-991-0070 Email: mwilwerding@canceralliance-ne.org
Omaha
Nebraska Cancer Specialists - Omaha
Status: Active
Contact: Gamini S. Soori
Phone: 402-991-0070 Email: mwilwerding@canceralliance-ne.org
Nebraska Methodist Hospital
Status: Active
Contact: Robert M. Langdon
Phone: 402-354-5144
Oncology Hematology West PC
Status: Active
Contact: Gamini S. Soori
Phone: 402-334-4773
Scottsbluff
Regional West Medical Center Cancer Center
Status: Active
Contact: Gamini S. Soori
Phone: 402-991-0070 Email: mwilwerding@canceralliance-ne.org

Nevada

Carson City
Carson Tahoe Regional Medical Center
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Henderson
21st Century Oncology-Henderson
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Cancer and Blood Specialists-Henderson
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Comprehensive Cancer Centers of Nevada - Henderson
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Comprehensive Cancer Centers of Nevada-Horizon Ridge
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Comprehensive Cancer Centers of Nevada-Southeast Henderson
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Las Vegas Cancer Center-Henderson
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Nevada Cancer Specialists-Saint Rose
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Las Vegas
21st Century Oncology
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
21st Century Oncology-Fort Apache
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
21st Century Oncology-Vegas Tenaya
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Ann M Wierman MD LTD
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Cancer and Blood Specialists-Shadow
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Cancer and Blood Specialists-Tenaya
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Cancer Therapy and Integrative Medicine
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Comprehensive Cancer Centers of Nevada
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Comprehensive Cancer Centers of Nevada - Central Valley
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Comprehensive Cancer Centers of Nevada - Northwest
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Comprehensive Cancer Centers of Nevada-Summerlin
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Desert West Surgery
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
HealthCare Partners Medical Group Oncology / Hematology-Centennial Hills
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
HealthCare Partners Medical Group Oncology / Hematology-Maryland Parkway
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
HealthCare Partners Medical Group Oncology / Hematology-San Martin
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
HealthCare Partners Medical Group Oncology / Hematology-Tenaya
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Hope Cancer Care of Nevada
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Las Vegas Cancer Center-Medical Center
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Nevada Cancer Specialists?Oakey
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Nevada Cancer Specialists-Fort Apache
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Nevada Cancer Specialists-Tenaya
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Radiation Oncology Centers of Nevada Central
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Radiation Oncology Centers of Nevada Southeast
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Summerlin Hospital Medical Center
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
University Cancer Center
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
University Medical Center of Southern Nevada
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Pahrump
Hope Cancer Care of Nevada-Pahrump
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Reno
Radiation Oncology Associates
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Renown Regional Medical Center
Status: Active
Contact: John Allan Ellerton
Phone: 702-384-0013 Email: research@sncrf.org
Saint Mary's Regional Medical Center
Status: Active
Contact: John Allan Ellerton Email: ecog.rss@jimmy.harvard.edu

New Jersey

Mount Holly
Virtua Memorial
Status: Active
Contact: James W. Lee
Phone: 609-914-6762
Voorhees
Virtua Voorhees
Status: Active
Contact: James W. Lee
Phone: 856-247-7395
Woodbury
Inspira Medical Center Woodbury
Status: Active
Contact: Carl J. Minniti Email: ecog.rss@jimmy.harvard.edu

New York

Elmira
Arnot Ogden Medical Center / Falck Cancer Center
Status: Active
Contact: Serge Dauphin
Phone: 607-271-7000

North Carolina

Clinton
Southeastern Medical Oncology Center-Clinton
Status: Active
Contact: James N. Atkins
Phone: 919-587-9077 Email: ecooke@cancersmoc.com
Goldsboro
Southeastern Medical Oncology Center-Goldsboro
Status: Active
Contact: James N. Atkins
Phone: 919-587-9077 Email: ecooke@cancersmoc.com
Wayne Memorial Hospital
Status: Active
Contact: James N. Atkins
Phone: 919-731-6687 Email: ecooke@cancersmoc.com
Hendersonville
Margaret R Pardee Memorial Hospital
Status: Active
Contact: James Earl Radford
Phone: 828-696-4716 Email: karen.morris@unchealth.unc.edu
Jacksonville
Onslow Memorial Hospital
Status: Active
Contact: James N. Atkins
Phone: 910-353-0824 Email: ecooke@cancersmoc.com
Southeastern Medical Oncology Center-Jacksonville
Status: Active
Contact: James N. Atkins
Phone: 910-353-0824 Email: ecooke@cancersmoc.com

North Dakota

Bismarck
Sanford Bismarck Medical Center
Status: Active
Contact: Preston D. Steen
Phone: 701-323-5760 Email: tamara.fischer@sanfordhealth.org
Fargo
Roger Maris Cancer Center
Status: Active
Contact: Preston D. Steen
Phone: 701-234-6161
Sanford Broadway Medical Center
Status: Active
Contact: Preston D. Steen
Phone: 800-437-4010
Minot
Trinity Cancer Care Center
Status: Active
Contact: Patanit Watanaboonyakhet
Phone: 800-862-0005

Ohio

Beachwood
UHHS-Chagrin Highlands Medical Center
Status: Active
Contact: Afshin Dowlati
Phone: 800-641-2422 Email: CTUReferral@UHhospitals.org
Beavercreek
Indu and Raj Soin Medical Center
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Belpre
Strecker Cancer Center-Belpre
Status: Active
Contact: Timothy David Moore
Phone: 800-523-3977 Email: sheree@columbusccop.org
Canton
Mercy Medical Center
Status: Active
Contact: Mitchell Haut
Phone: 888-293-4673
Centerville
Dayton Physicians LLC-Miami Valley South
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Miami Valley Hospital South
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Chardon
Geauga Hospital
Status: Active
Contact: Afshin Dowlati
Phone: 800-641-2422 Email: CTUReferral@UHhospitals.org
Chillicothe
Adena Regional Medical Center
Status: Active
Contact: Timothy David Moore
Phone: 877-779-7585 Email: sheree@columbusccop.org
Cincinnati
Oncology Hematology Care Inc-Kenwood
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Cleveland
Case Western Reserve University
Status: Active
Contact: Afshin Dowlati
Phone: 800-641-2422 Email: CTUReferral@UHhospitals.org
MetroHealth Medical Center
Status: Active
Contact: Bruce J. Averbook
Phone: 216-778-8526 Email: dstrater@metrohealth.org
Columbus
Columbus Oncology and Hematology Associates Inc
Status: Active
Contact: Timothy David Moore
Phone: 614-488-2118 Email: sheree@columbusccop.org
Doctors Hospital
Status: Active
Contact: Timothy David Moore
Phone: 614-566-3275 Email: sheree@columbusccop.org
Grant Medical Center
Status: Active
Contact: Timothy David Moore
Phone: 614-566-4475 Email: sheree@columbusccop.org
Mount Carmel East Hospital
Status: Active
Contact: Timothy David Moore
Phone: 614-488-2118 Email: sheree@columbusccop.org
Mount Carmel Health Center West
Status: Active
Contact: Timothy David Moore
Phone: 614-234-5433 Email: sheree@columbusccop.org
Riverside Methodist Hospital
Status: Active
Contact: Timothy David Moore
Phone: 614-566-4475 Email: sheree@columbusccop.org
The Mark H Zangmeister Center
Status: Active
Contact: Timothy David Moore
Phone: 614-488-2118 Email: sheree@columbusccop.org
Dayton
Dayton Physicians LLC-Samaritan North
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Good Samaritan Hospital - Dayton
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Miami Valley Hospital
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Samaritan North Health Center
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Delaware
Delaware Health Center-Grady Cancer Center
Status: Active
Contact: Timothy David Moore
Phone: 740-615-0227 Email: sheree@columbusccop.org
Delaware Radiation Oncology
Status: Active
Contact: Timothy David Moore Email: ecog.rss@jimmy.harvard.edu
Grady Memorial Hospital
Status: Active
Contact: Timothy David Moore
Phone: 740-615-2403 Email: sheree@columbusccop.org
Elyria
Mercy Cancer Center-Elyria
Status: Active
Contact: Afshin Dowlati
Phone: 800-641-2422 Email: CTUReferral@UHhospitals.org
Findlay
Armes Family Cancer Center
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Blanchard Valley Hospital
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Orion Cancer Care
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Franklin
Atrium Medical Center-Middletown Regional Hospital
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Dayton Physicians LLC-Atrium
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Greenville
Dayton Physicians LLC-Wayne
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Wayne Hospital
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Kettering
First Dayton Cancer Care
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Greater Dayton Cancer Center
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Kettering Medical Center
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Lancaster
Fairfield Medical Center
Status: Active
Contact: Timothy David Moore
Phone: 740-687-8863 Email: sheree@columbusccop.org
Mansfield
OhioHealth Mansfield Hospital
Status: Active
Contact: Timothy David Moore
Phone: 419-526-8018 Email: sheree@columbusccop.org
Marietta
Marietta Memorial Hospital
Status: Active
Contact: Timothy David Moore
Phone: 800-523-3977 Email: sheree@columbusccop.org
Marion
OhioHealth Marion General Hospital
Status: Active
Contact: Timothy David Moore
Phone: 614-488-2118 Email: sheree@columbusccop.org
Maumee
Toledo Clinic Cancer Centers-Maumee
Status: Active
Contact: Rex B. Mowat Email: ecog.rss@jimmy.harvard.edu
Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
Status: Active
Contact: Rex B. Mowat
Phone: 419-891-5600ext4
Mentor
Lake University Ireland Cancer Center
Status: Active
Contact: Afshin Dowlati
Phone: 800-641-2422 Email: CTUReferral@UHhospitals.org
Middleburg Heights
Southwest General Health Center Ireland Cancer Center
Status: Active
Contact: Afshin Dowlati
Phone: 800-641-2422 Email: CTUReferral@UHhospitals.org
Mount Vernon
Knox Community Hospital
Status: Active
Contact: Timothy David Moore
Phone: 740-393-9000 Email: sheree@columbusccop.org
Newark
Licking Memorial Hospital
Status: Active
Contact: Timothy David Moore
Phone: 740-348-4000 Email: sheree@columbusccop.org
Newark Radiation Oncology
Status: Active
Contact: Timothy David Moore
Phone: 614-488-2118 Email: sheree@columbusccop.org
Parma
University Hospitals Parma Medical Center
Status: Active
Contact: Afshin Dowlati
Phone: 800-641-2422 Email: CTUReferral@UHhospitals.org
Perrysburg
Mercy Health Perrysburg Cancer Center
Status: Active
Contact: Rex B. Mowat
Phone: 419-479-5605 Email: pshoup@toledoclinic.com
Portsmouth
Southern Ohio Medical Center
Status: Active
Contact: Timothy David Moore
Phone: 614-488-2118 Email: sheree@columbusccop.org
Springfield
Springfield Regional Cancer Center
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Springfield Regional Medical Center
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Toledo
Mercy Saint Anne Hospital
Status: Active
Contact: Rex B. Mowat
Phone: 419-407-1160
Toledo Clinic Cancer Centers-Toledo
Status: Active
Contact: Rex B. Mowat
Phone: 800-444-3561
Troy
Dayton Physicians LLC-Upper Valley
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Upper Valley Medical Center
Status: Active
Contact: Howard M. Gross
Phone: 937-775-1350 Email: som_dcop@wright.edu
Westerville
Saint Ann's Hospital
Status: Active
Contact: Timothy David Moore Email: ecog.rss@jimmy.harvard.edu
Westlake
UH Seidman Cancer Center at Saint John Medical Center
Status: Active
Contact: Afshin Dowlati
Phone: 800-641-2422 Email: CTUReferral@UHhospitals.org
UHHS-Westlake Medical Center
Status: Active
Contact: Afshin Dowlati
Phone: 800-641-2422 Email: CTUReferral@UHhospitals.org
Zanesville
Genesis Healthcare System Cancer Care Center
Status: Active
Contact: Timothy David Moore
Phone: 740-454-5232 Email: sheree@columbusccop.org

Oklahoma

Lawton
Cancer Centers of Southwest Oklahoma Research
Status: Active
Contact: Raid Aljumaily
Phone: 877-231-4440
Oklahoma City
University of Oklahoma Health Sciences Center
Status: Active
Contact: Raid Aljumaily
Phone: 405-271-8777 Email: ou-clinical-trials@ouhsc.edu
Tulsa
Oklahoma Cancer Specialists and Research Institute-Tulsa
Status: Active
Contact: Raid Aljumaily
Phone: 918-505-3200

Oregon

Baker City
Saint Alphonsus Medical Center-Baker City
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Gresham
Legacy Mount Hood Medical Center
Status: Active
Name Not Available
Phone: 503-413-2150
Ontario
Saint Alphonsus Medical Center-Ontario
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Portland
Legacy Good Samaritan Hospital and Medical Center
Status: Active
Name Not Available
Phone: 800-220-4937 Email: cancer@lhs.org
Tualatin
Legacy Meridian Park Hospital
Status: Active
Name Not Available
Phone: 503-413-1742

Pennsylvania

Allentown
Lehigh Valley Hospital-Cedar Crest
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Bethlehem
Lehigh Valley Hospital - Muhlenberg
Status: Active
Contact: Philip J. Stella
Phone: 734-712-3671 Email: stephanie.couch@stjoeshealth.org
Bryn Mawr
Bryn Mawr Hospital
Status: Active
Name Not Available
Phone: 484-476-2649 Email: turzoe@mlhs.org
Danville
Geisinger Medical Center
Status: Active
Contact: Rajiv Panikkar
Phone: 570-271-5251 Email: HemonCCTrials@geisinger.edu
East Stroudsburg
Pocono Medical Center
Status: Active
Contact: Philip J. Stella
Phone: 570-422-1700 Email: ann.foster@lvhn.org
Ephrata
Ephrata Cancer Center
Status: Active
Contact: Amir Tabatabai
Phone: 717-721-4840
Ephrata Community Hospital
Status: Active
Contact: Amir Tabatabai
Phone: 888-823-5923 Email: ctsucontact@westat.com
Gettysburg
Adams Cancer Center
Status: Active
Contact: Amir Tabatabai
Phone: 877-441-7957
Hanover
Cherry Tree Cancer Center
Status: Active
Contact: Amir Tabatabai
Phone: 877-441-7957
Hazleton
Geisinger Medical Center-Cancer Center Hazleton
Status: Active
Contact: Rajiv Panikkar
Phone: 570-459-2901 Email: HemonCCTrials@geisinger.edu
Lehigh Valley Hospital-Hazleton
Status: Active
Contact: Philip J. Stella Email: ecog.rss@jimmy.harvard.edu
Lebanon
Sechler Family Cancer Center
Status: Active
Contact: Amir Tabatabai
Phone: 717-741-8303 Email: doxenberg@wellspan.org
Lewisburg
Geisinger Medical Oncology-Lewisburg
Status: Active
Contact: Rajiv Panikkar
Phone: 570-374-8555 Email: HemonCCTrials@geisinger.edu
Lewistown
Lewistown Hospital
Status: Active
Contact: Rajiv Panikkar
Phone: 717-242-7703 Email: HemonCCTrials@geisinger.edu
Media
Riddle Memorial Hospital
Status: Active
Name Not Available
Phone: 484-476-2649 Email: turzoe@mlhs.org
Paoli
Paoli Memorial Hospital
Status: Active
Name Not Available
Phone: 484-476-2649 Email: turzoe@mlhs.org
Philadelphia
ECOG-ACRIN Cancer Research Group
Status: Active
Contact: Ticiana A. Leal
Phone: 608-263-9063 Email: tbleal@medicine.wisc.edu
Pottstown
Pottstown Hospital
Status: Active
Contact: Wei Song
Phone: 610-327-7544
Pottsville
Geisinger Cancer Services-Pottsville
Status: Active
Contact: Rajiv Panikkar
Phone: 800-275-6401 Email: HemonCCTrials@geisinger.edu
Sayre
Guthrie Medical Group PC-Robert Packer Hospital
Status: Active
Contact: Philip Andrew Lowry
Phone: 800-836-0388
Scranton
Community Medical Center
Status: Active
Contact: Rajiv Panikkar
Phone: 570-703-4768 Email: HemonCCTrials@geisinger.edu
Selinsgrove
Geisinger Medical Oncology-Selinsgrove
Status: Active
Contact: Rajiv Panikkar
Phone: 570-374-8555 Email: HemonCCTrials@geisinger.edu
State College
Geisinger Medical Group
Status: Active
Contact: Rajiv Panikkar
Phone: 570-271-5251 Email: HemonCCTrials@geisinger.edu
Wilkes-Barre
Geisinger Wyoming Valley / Henry Cancer Center
Status: Active
Contact: Rajiv Panikkar
Phone: 570-271-5251 Email: HemonCCTrials@geisinger.edu
Wynnewood
Lankenau Medical Center
Status: Active
Name Not Available
Phone: 484-476-2649 Email: turzoe@mlhs.org
York
WellSpan Health-York Cancer Center
Status: Active
Contact: Amir Tabatabai
Phone: 877-441-7957
WellSpan Health-York Hospital
Status: Active
Contact: Amir Tabatabai
Phone: 877-441-7957

South Carolina

Charleston
Medical University of South Carolina
Status: Active
Contact: John M. Wrangle
Phone: 843-792-9321 Email: hcc-clinical-trials@musc.edu
Greenwood
Self Regional Healthcare
Status: Active
Contact: John M. Wrangle
Phone: 864-725-4771 Email: nmcgaha@selfregional.org

South Dakota

Sioux Falls
Sanford Cancer Center Oncology Clinic
Status: Active
Contact: Preston D. Steen
Phone: 605-312-3320
Sanford USD Medical Center - Sioux Falls
Status: Active
Contact: Preston D. Steen
Phone: 605-312-3320 Email: OncologyClinicalTrialsSF@SanfordHealth.org

Tennessee

Bristol
Wellmont Bristol Regional Medical Center
Status: Active
Contact: Asheesh Shipstone
Phone: 423-578-8538 Email: justin.reynolds@wellmont.org
Johnson City
Wellmont Medical Associates Oncology and Hematology-Johnson City
Status: Active
Contact: Asheesh Shipstone
Phone: 423-578-8538 Email: justin.reynolds@wellmont.org
Kingsport
Wellmont Holston Valley Hospital and Medical Center
Status: Active
Contact: Asheesh Shipstone
Phone: 423-578-8538 Email: justin.reynolds@wellmont.org
Wellmont Medical Associates Oncology and Hematology-Kingsport
Status: Active
Contact: Asheesh Shipstone
Phone: 423-578-8538 Email: justin.reynolds@wellmont.org

Virginia

Bristol
Wellmont Medical Associates-Bristol
Status: Active
Contact: Asheesh Shipstone
Phone: 423-578-8538 Email: justin.reynolds@wellmont.org
Charlottesville
University of Virginia Cancer Center
Status: Active
Contact: Ryan D. Gentzler
Phone: 434-243-6303 Email: PAS9E@virginia.edu
Norton
Southwest VA Regional Cancer Center
Status: Active
Contact: Asheesh Shipstone
Phone: 423-578-8538 Email: justin.reynolds@wellmont.org

Washington

Vancouver
Legacy Salmon Creek Hospital
Status: Active
Name Not Available
Phone: 503-413-2150

Wisconsin

Antigo
Langlade Hospital and Cancer Center
Status: Active
Contact: Harish G. Ahuja
Phone: 715-623-9869 Email: Juli.Alford@aspirus.org
Green Bay
Saint Vincent Hospital Cancer Center at Saint Mary's
Status: Active
Contact: Brian Leslie Burnette Email: ecog.rss@jimmy.harvard.edu
Saint Vincent Hospital Cancer Center Green Bay
Status: Active
Contact: Brian Leslie Burnette
Phone: 920-433-8889 Email: Christy.Gilchrist@hshs.org
Madison
University of Wisconsin Hospital and Clinics
Status: Active
Contact: Ticiana A. Leal
Phone: 800-622-8922
Manitowoc
Holy Family Memorial Hospital
Status: Active
Contact: Brian Leslie Burnette
Phone: 920-320-2749
Marinette
Saint Vincent Hospital Cancer Center at Marinette
Status: Active
Contact: Brian Leslie Burnette
Phone: 920-433-8889 Email: Christy.Gilchrist@hshs.org
New Richmond
Cancer Center of Western Wisconsin
Status: Active
Contact: David Mark King
Phone: 952-993-1517 Email: mmcorc@healthpartners.com
Oconto Falls
Green Bay Oncology - Oconto Falls
Status: Active
Contact: Brian Leslie Burnette
Phone: 920-433-8889 Email: Christy.Gilchrist@hshs.org
Sheboygan
HSHS Saint Nicholas Hospital
Status: Active
Contact: Brian Leslie Burnette
Phone: 920-433-8889 Email: Christy.Gilchrist@hshs.org
Sturgeon Bay
Saint Vincent Hospital Cancer Center at Sturgeon Bay
Status: Active
Contact: Brian Leslie Burnette
Phone: 920-433-8889 Email: Christy.Gilchrist@hshs.org
Wausau
Aspirus Regional Cancer Center
Status: Active
Contact: Harish G. Ahuja
Phone: 877-405-6866
Wisconsin Rapids
Aspirus UW Cancer Center
Status: Active
Contact: Harish G. Ahuja
Phone: 715-422-7718

Wyoming

Cheyenne
Cheyenne Regional Medical Center-West
Status: Active
Contact: Keren Sturtz
Phone: 303-777-2663 Email: ccrp@co-cancerresearch.org
Cody
Billings Clinic-Cody
Status: Active
Contact: Benjamin T. Marchello
Phone: 800-996-2663 Email: research@billingsclinic.org
Sheridan
Welch Cancer Center
Status: Active
Contact: Benjamin T. Marchello
Phone: 406-969-6060 Email: mccinfo@mtcancer.org

Trial Objectives and Outline

PRIMARY OBJECTIVES:

I. To evaluate the progression-free survival (PFS) of patients with extensive stage small cell lung cancer (ED-SCLC) treated with cisplatin/carboplatin and etoposide (CE) or CE with nivolumab (CEN) as front-line treatment.

SECONDARY OBJECTIVES:

I. To estimate overall survival of patients with ED-SCLC treated with cisplatin/carboplatin and etoposide (CE) or CE with nivolumab (CEN) as front-line treatment.

II. To assess best overall response rate after treatment with CE with or without nivolumab as first line treatment.

III. To evaluate the toxicity profile of nivolumab with CE.

TERTIARY OBJECTIVES:

I. To evaluate immune biomarkers and biomarkers correlatives.

II. To evaluate serial circulating tumor deoxyribonucleic acid (DNA) and explore whether clinical outcome is associated with fluctuations in DNA levels following the administration of therapy.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM A: Patients receive nivolumab intravenously (IV) over 30 minutes on day 1, carboplatin IV over 30-60 minutes on day 1 or cisplatin IV over 60-120 minutes on day 1, and etoposide IV over 60-120 minutes on days 1-3. Treatment repeats every 21 days for up to 4 courses in the absence of disease progression or unacceptable toxicity. Patients continue to receive nivolumab IV over 30 minutes every 2 weeks for up to 2 years.

ARM B: Patients receive carboplatin IV over 30-60 minutes on day 1 or cisplatin IV over 60-120 minutes on day 1, and etoposide IV over 60-120 minutes on days 1-3. Treatment repeats every 21 days for up to 4 courses in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 3 months for less than 2 years from registration, every 6 months if the patient is 2-3 years from registration, and yearly for up to 5 years.

Trial Phase & Type

Trial Phase

Phase II

Trial Type

Treatment

Lead Organization

Lead Organization
ECOG-ACRIN Cancer Research Group

Principal Investigator
Ticiana A. Leal

Trial IDs

Primary ID EA5161
Secondary IDs NCI-2017-02367
Clinicaltrials.gov ID NCT03382561